scleroderma

Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab
Jérôme Avouac, Paolo Airó, Nicolas Carlier, Marco Matucci-Cerinic, Yannick Allanore

Annals of the Rheumatic Diseases Mar 2021, 80 (3) e37; DOI: 10.1136/annrheumdis-2020-217864
Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma
Rebecca L Ross, Clarissa Corinaldesi, Gemma Migneco, Ian M Carr, Agne Antanaviciute, Christopher W Wasson, Antonio Carriero, Jörg H W Distler, Steve Holmes, Yasser M El-Sherbiny, Clive S McKimmie, Francesco Del Galdo

Annals of the Rheumatic Diseases Feb 2021, annrheumdis-2020-218439; DOI: 10.1136/annrheumdis-2020-218439
PASTUL questionnaire: a tool for self-assessment of scleroderma skin during the COVID-19 pandemic
Julia Spierings, Voon Ong, Christopher P Denton

Annals of the Rheumatic Diseases Jan 2021, annrheumdis-2020-219775; DOI: 10.1136/annrheumdis-2020-219775
Autoantibodies targeting telomere-associated proteins in systemic sclerosis
Brittany L Adler, Francesco Boin, Paul J Wolters, Clifton O Bingham, Ami A Shah, Carol Greider, Livia Casciola-Rosen, Antony Rosen

Annals of the Rheumatic Diseases Jan 2021, annrheumdis-2020-218918; DOI: 10.1136/annrheumdis-2020-218918
Arg206Cys substitution in DNASE1L3 causes a defect in DNASE1L3 protein secretion that confers risk of systemic lupus erythematosus
Latanya N Coke, Hongxiu Wen, Mary Comeau, Mustafa H Ghanem, Andrew Shih, Christine N Metz, Wentian Li, Carl D Langefeld, Peter K Gregersen, Kim R Simpfendorfer

Annals of the Rheumatic Diseases Jan 2021, annrheumdis-2020-218810; DOI: 10.1136/annrheumdis-2020-218810
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
Anna-Maria Hoffmann-Vold, Yannick Allanore, Margarida Alves, Cathrine Brunborg, Paolo Airó, Lidia P Ananieva, László Czirják, Serena Guiducci, Eric Hachulla, Mengtao Li, Carina Mihai, Gabriela Riemekasten, Petros P Sfikakis, Otylia Kowal-Bielecka, Antonella Riccardi, Oliver Distler

Annals of the Rheumatic Diseases Feb 2021, 80 (2) 219-227; DOI: 10.1136/annrheumdis-2020-217455
Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement
Kimberly Showalter, Robert Spiera, Cynthia Magro, Phaedra Agius, Viktor Martyanov, Jennifer M Franks, Roshan Sharma, Heather Geiger, Tammara A Wood, Yaxia Zhang, Caryn R Hale, Jackie Finik, Michael L Whitfield, Dana E Orange, Jessica K Gordon

Annals of the Rheumatic Diseases Feb 2021, 80 (2) 228-237; DOI: 10.1136/annrheumdis-2020-217840
Correspondence on ‘Systemic sclerosis and the COVID-19 pandemic—World Scleroderma Foundation preliminary advice for patient management’
Elena Snarskaya, Kseniia Vasileva

Annals of the Rheumatic Diseases Jan 2021, annrheumdis-2020-219489; DOI: 10.1136/annrheumdis-2020-219489
Response to: ‘Correspondence on ‘Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management’’ by Snarskaya and Vasileva
Cosimo Bruni, Marco Matucci-Cerinic

Annals of the Rheumatic Diseases Jan 2021, annrheumdis-2020-219533; DOI: 10.1136/annrheumdis-2020-219533
New composite endpoint in early diffuse cutaneous systemic sclerosis: revisiting the provisional American College of Rheumatology Composite Response Index in Systemic Sclerosis
Dinesh Khanna, Suiyuan Huang, Celia J F Lin, Cathie Spino

Annals of the Rheumatic Diseases Nov 2020, annrheumdis-2020-219100; DOI: 10.1136/annrheumdis-2020-219100

Main menu

scleroderma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

scleroderma

Pages